---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-043336"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-04-10T23:59:59+00:00"
generated_at: "2026-06-04T00:30:52.607609+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Renalytix repays $1.06M of convertible bonds with ADSs; outstanding principal now $12.72M

## Summary
- Issued 1,818,081 ADSs (3,636,162 ordinary shares) on April 11, 2024 to settle $1.06M of principal and interest due April 7, 2024.
- Principal remaining on 5.5% convertible bonds due April 2027 reduced by $1.06M to $12.72M.
- New ordinary shares admitted to AIM on April 12, 2024; total voting rights rise to 123,552,349.
- Shares issued without SEC registration under Section 3(a)(9) exemption.
- Repayment covers quarterly installment for period from January 8, 2024 to April 7, 2024.

## SEC filing metadata
- accession: 0000950170-24-043336
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-04-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/0000950170-24-043336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024043336/rnlx-20240410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-043336
- JSON: https://secwatch.observer/filing/0000950170-24-043336.json
- Plain text: https://secwatch.observer/filing/0000950170-24-043336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.